{"id":9232,"date":"2020-06-19T20:02:27","date_gmt":"2020-06-20T00:02:27","guid":{"rendered":"https:\/\/imedcprod.wpengine.com\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/"},"modified":"2020-06-19T20:02:27","modified_gmt":"2020-06-20T00:02:27","slug":"mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb","status":"publish","type":"news","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/","title":{"rendered":"MNC r\u00e9pond \u00e0 la publication de lignes directrices r\u00e9vis\u00e9es du CEPMB"},"content":{"rendered":"<p><strong>Ottawa, le 19 juin <\/strong><strong>2020<\/strong> \u2013 M\u00e9dicaments novateurs Canada a fait para\u00eetre aujourd\u2019hui la d\u00e9claration suivante en r\u00e9ponse \u00e0 la publication des Lignes directrices r\u00e9vis\u00e9es sur l\u2019\u00e9tablissement des prix du CEPMB :<\/p>\n<p>\u00ab Nous venons tout juste de recevoir les Lignes directrices r\u00e9vis\u00e9es et nous les examinerons minutieusement, en consultation avec nos membres, \u00e0 la suite de quoi nous serons en mesure de commenter plus en d\u00e9tail.<\/p>\n<p>\u00ab\u00a0Nous demeurons profond\u00e9ment pr\u00e9occup\u00e9s par l\u2019impact que le <em>R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s<\/em> modifi\u00e9 aura sur l\u2019acc\u00e8s des Canadiens \u00e0 des m\u00e9dicaments abordables et novateurs et sur la capacit\u00e9 du pays \u00e0 attirer des investissements dans notre secteur des sciences de la vie. Comme l\u2019a montr\u00e9 la crise de la COVID-19, les compagnies de m\u00e9dicaments novateurs du Canada sont essentielles \u00e0 la sant\u00e9 et au bien-\u00eatre de tous les Canadiens, et nous avons besoin d\u2019un environnement r\u00e9glementaire qui les encourage \u00e0 cro\u00eetre et \u00e0 prosp\u00e9rer. Nous serons ravis de participer activement au processus de consultation de 30 jours.<\/p>\n<p>\u00ab\u00a0Il n\u2019est pas trop tard pour trouver une solution qui pr\u00e9viendra les cons\u00e9quences n\u00e9gatives de la r\u00e9glementation modifi\u00e9e, tout en permettant au gouvernement f\u00e9d\u00e9ral d\u2019atteindre ses objectifs de politique publique.\u00a0\u00bb<\/p>\n<h2>\u00c0 propos de M\u00e9dicaments novateurs Canada<\/h2>\n<p>M\u00e9dicaments novateurs Canada est la voix nationale de l\u2019industrie pharmaceutique innovatrice canadienne. Nous plaidons en faveur de politiques qui permettent la d\u00e9couverte, le d\u00e9veloppement et la commercialisation de m\u00e9dicaments et vaccins novateurs qui am\u00e9liorent la vie de tous les Canadiens. Nous appuyons l\u2019engagement de nos membres d\u2019\u00eatre un partenaire pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien.<\/p>\n<p style=\"text-align: center;\">\u2013 30 \u2013<\/p>\n<h2>Pour de plus amples renseignements\u00a0:<\/h2>\n<p>Sarah Dion-Marquis<br \/>\nDirectrice, M\u00e9dia et relations publiques<br \/>\nT\u00e9l\u00e9phone\u00a0: (613)\u00a0769-6510<br \/>\nCourriel\u00a0:\u00a0<a href=\"mailto:sdmarquis@imc-mnc.ca\">sdmarquis@imc-mnc.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MNC a fait para\u00eetre aujourd\u2019hui [&#8230;]<\/p>\n","protected":false},"featured_media":19746,"template":"","topic":[],"team-member-id":[],"news-category":[176],"news-tag":[],"class_list":["post-9232","news","type-news","status-publish","has-post-thumbnail","hentry","news-category-communique"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MNC r\u00e9pond \u00e0 la publication de lignes directrices r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MNC r\u00e9pond \u00e0 la publication de lignes directrices r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"MNC a fait para\u00eetre aujourd\u2019hui [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\\\/\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\\\/\",\"name\":\"MNC r\u00e9pond \u00e0 la publication de lignes directrices r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/IMC-responds-to-the-release-of-revised-PMPRB-guidelines-scaled.jpg\",\"datePublished\":\"2020-06-20T00:02:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\\\/#primaryimage\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/IMC-responds-to-the-release-of-revised-PMPRB-guidelines-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/IMC-responds-to-the-release-of-revised-PMPRB-guidelines-scaled.jpg\",\"width\":1980,\"height\":1320},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newsroom\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/newsroom\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Newsroom\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/newsroom\\\/all-news\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"MNC r\u00e9pond \u00e0 la publication de lignes directrices r\u00e9vis\u00e9es du CEPMB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MNC r\u00e9pond \u00e0 la publication de lignes directrices r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/","og_locale":"fr_FR","og_type":"article","og_title":"MNC r\u00e9pond \u00e0 la publication de lignes directrices r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada","og_description":"MNC a fait para\u00eetre aujourd\u2019hui [...]","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/","og_site_name":"Innovative Medicines Canada","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/","name":"MNC r\u00e9pond \u00e0 la publication de lignes directrices r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2020\/06\/IMC-responds-to-the-release-of-revised-PMPRB-guidelines-scaled.jpg","datePublished":"2020-06-20T00:02:27+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2020\/06\/IMC-responds-to-the-release-of-revised-PMPRB-guidelines-scaled.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2020\/06\/IMC-responds-to-the-release-of-revised-PMPRB-guidelines-scaled.jpg","width":1980,"height":1320},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-repond-a-la-publication-de-lignes-directrices-revisees-du-cepmb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/"},{"@type":"ListItem","position":3,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/all-news\/"},{"@type":"ListItem","position":4,"name":"MNC r\u00e9pond \u00e0 la publication de lignes directrices r\u00e9vis\u00e9es du CEPMB"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news\/9232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/19746"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=9232"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=9232"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=9232"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-category?post=9232"},{"taxonomy":"news-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-tag?post=9232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}